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Corneal endothelial cells play a crucial role in maintaining
corneal transparency. Corneal clarity requires a net
movement of fluid from the corneal stroma to the aqueous
humor. This flux depends on corneal endothelial ion
transports and regulation [1,2]. Recent studies have reported
that an absence of extracellular calcium can lead to rounding
of endothelial cells, their losing of the apical junction, and
increasing paracellular calcium permeability. These changes
result in rapid corneal swelling [3]. After calcium is added
to the solution, however, normal endothelial configuration
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The aim of this study was to estimate the effects of various antiglaucoma drugs including betaxolol, timolol,
levobunolol, brimonidine, carteolol, dipivefrin, dorzolamide, brinzolamide, latanoprost, unoprostone, and
pilocarpine on intracellular free Ca2+ ([Ca2+]i) mobility in cultured bovine corneal endothelial cells. Various
antiglaucoma drugs were diluted from original concentrations to 1/100, 1/1,000, and 1/10,000. The [Ca2+]i
mobility was studied by spectrofluorophotometry after loading with the ester of fura-2 (fura-2/AM).
It was found that timolol (58 µM and 5.8 µM), levobunolol (171 µM, 17.1 µM, and 1.71 µM), betaxolol
(162 µM, 16.2 µM, and 1.62 µM), carteolol (680 µM and 68 µM), dipivefrin (28 µM and 2.8 µM), dorzolamide
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0.282 µM), and pilocarpine (408 µM and 40.8 µM) induced a significant increase in [Ca2+]i. Nevertheless, only
brimonidine (68 µM and 6.8 µM) decreased [Ca2+]i concentration significantly. Benzalkonium chloride
preservative did not affect [Ca2+]i after addition of 0.001, 0.0001 and 0.00001 mg/mL to cells. These results
indicate that all antiglaucoma drugs may affect the physiologic function of corneal endothelial cells through
change of [Ca2+]i.mobility.
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is restored [4]. In the corneal endothelial cell membrane, the
Na+/K+ cation-sensitive channel is activated by intracellular
calcium [5]. Adenosine triphosphate (ATP), purinergic
receptor agonists, and endoplasmic reticulum (ER) Ca2+-
pump inhibitor are reported to enhance HCO3
– permeability
in corneal endothelium via increase in intracellular free
Ca2+ ([Ca2+]i) [6]. The swelling rate of corneas increased in
the presence of the calcium channel antagonist verapamil
[7].
Many glaucoma patients require the administration of
antiglaucoma drugs for a long period of time unless the
intraocular pressure is controlled by other alternatives such
as laser therapy or surgery. Under such circumstances, the
corneal endothelium is continuously soaked in antiglaucoma
drugs for a protracted period. The physiologic function of
corneal endothelial cells may change gradually during the
© 2006 Elsevier. All rights reserved.
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process of drug administration. Our previous study shows
that the [Ca2+]i in corneal endothelial cells is inhibited by
isoproterenol and norepinephrine but enhanced by
propranolol [8]. Until now, the effects of antiglaucoma
drugs on the change of calcium signal transduction of
corneal endothelial cells have had little investigation. In the
present study, we evaluated the effects of various
commercial antiglaucoma drugs including timolol,
levobunolol, betaxolol, carteolol, dipivefrin, brimonidine,
dorzolamide, brinzolamide, latanoprost, unoprostone, and
pilocarpine on the [Ca2+]i in cultured bovine corneal
endothelial (BCE) cells.
MATERIALS AND METHODS
Materials
Culture materials, including trypsin, minimal essential
medium (MEM), glutamine, gentamicin, and fetal bovine
serum (FBS), were obtained from GIBCO (Grand Island,
NY, USA). Benzalkonium chloride, ester of fura-2 (fura-2/
AM), and bovine serum albumin (BSA) were purchased
from Sigma Chemical (St. Louis, MO, USA). Commercially
available preparations of antiglaucoma drugs, namely
0.5% (16.2 mM) betaxolol (Betoptic, Alcon, containing 0.1
mg/mL benzalkonium chloride), 0.25% (5.8 mM) timolol
(Timoptol, Merck Sharp & Dohme-Chibret, containing
0.048 mg/mL benzalkonium chloride), 0.5% (17.1 mM)
levobunolol (Bunolgan, Allergan, containing 0.04 mg/mL
benzalkonium chloride), 1% (68 mM) carteolol (Arteoptic,
Otsuka, containing 0.005 mg/mL benzalkonium chloride),
0.2% (6.8 mM) brimonidine (Alphagan, Allergan, containing
0.01 mg/mL benzalkonium chloride), 0.1% (2.8 mM)
dipivefrin (Propine, Allergan, containing 0.04 mg/mL
benzalkonium chloride), 2% (61.6 mM) dorzolamide
(Trusopt, Merck Sharp & Dohme-Chibret, containing 0.075
mg/mL benzalkonium chloride), 1% (26 mM) brinzolamide
(Azopt, Alcon, containing 0.1 mg/mL benzalkonium
chloride), 0.005% (0.11 mM) latanoprost (Xalatan, Pharmacia
& Upjohn, containing 0.08 mg/mL benzalkonium chloride),
0.12% (2.82 mM) unoprostone (Rescula, Fujisawa, containing
0.015 mg/mL benzalkonium chloride) and 1% (40.8 mM)
pilocarpine (Spersacarpine, Dispersa, containing 0.1 mg/
mL benzalkonium chloride), were diluted with control
buffer containing 129 mM NaCl, 2 mM CaCl2, 4.7 mM KCl,
1.25 mM MgSO4, and 10 mM Na2PO4 at pH 7.4 to make three
dilutions of these drugs, from 1/100, 1/1,000, to 1/10,000,
for the calcium experiment. All other chemicals were
obtained from Merck (Darmstadt, Germany).
Culture of bovine corneal endothelial cells
BCE C/D-1b cells, a stable cell line derived from bovine
corneal endothelium, were obtained from ATCC (American
Type Culture Collection). Cells were grown in MEM containing
20% FBS, 3.8 mM L-glutamine, and 50 µg/mL gentamicin
according to our previously published method [9]. Culture
conditions were maintained in a humidified chamber with 5%
CO2 at 37°C, and the medium was changed every 2 or 3 days.
Detection of intracellular calcium by
spectrofluorometry
To determine the effects of antiglaucoma drugs on [Ca2+]i,
various concentrations of drugs were diluted with control
buffer containing 129 mM NaCl, 2 mM CaCl2, 4.7 mM KCl,
1.25 mM MgSO4, and 10 mM Na2PO4 at pH 7.4 to make three
dilutions of these drugs from their original concentrations to
1/100, 1/1,000, and 1/10,000. [Ca2+]i was measured according
to our previously published method [10]. Approximately
106 cells/mL were loaded with 2  M fura-2/AM and 0.25%
BSA for 60 minutes at 37°C in control buffer containing
129 mM NaCl, 2 mM CaCl2, 4.7 mM KCl, 1.25 mM MgSO4,
and 10 mM Na2PO4 at pH 7.4. The cells were then washed
and resuspended in control buffer. Fura-2 fluorescence
measurements were performed in a water-jacketed cuvette
containing 1 mL of control buffer and 1 mL of cells. Fluorescence
was monitored with a fluorescent spectrophotometer
(Shimadzu RF-5301PC, Japan) by continuously recording
excitation signals at 340 and 380 nm, and emission signals at
510 nm at 1-second intervals at 25°C. After equilibration with
control buffer, various drugs were added to the cells for
specific experiments. [Ca2+]i was estimated and calculated
according to the equation, [Ca2+]I = Kdβ(R – Rmin)/(Rmax – R),
where the value of β is equivalent to 380 nm at Rmin/380 nm
at Rmax, and a Kd (dissociation constant) value of 155 nM is
assumed Maximal (Rmax) and minimal (Rmin) fluorescence
values were obtained by adding Triton X-100 (0.1%) and
EGTA (20 mM) sequentially at the end of experiments.
Autofluorescence was determined by quenching fura-2/AM
fluorescence with 2 mM MnCl2, and 340 nm/380 nm
quenching values were subtracted before calculating the data.
Calculation and statistics
The net area under the response curve (AUC) of [Ca2+]i
increase with baseline subtracted was integrated with six
experiments. The values were presented as the mean ± SEM
of six different experiments. All data were analyzed with
analysis of variance followed by comparison with a Dunnette
test. The values were considered significantly different
from the control group at p < 0.05.
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RESULTS
After treatment of cells with 58  µM and 5.8 µM timolol for 200
seconds, the drug-induced [Ca2+]i AUCs  were significantly
increased to 136 ± 4% and 119 ± 3% when compared with the
AUCs for control cells, which was assumed as a 100% response
(Figure 1A). Levobunolol concentrations of 171 µM, 17.1 µM,
and 1.71 µM all induced significant increases in the AUCs
for [Ca2+]i to 409 ± 4%, 353 ± 3%, and 136 ± 5% (Figure 1B).
Treatment of cells with betaxolol at 162 µM, 16.2 µM,
and 1.62 µM also resulted in significant AUC increases for
[Ca2+]i to 123 ± 5%, 118 ± 4%, and 114 ± 4%, when compared
with the AUC for control cells (Figure 2A). When carteolol
was added at concentrations of 680 µM and 68 µM for 200
seconds, the amount of drug-induced [Ca2+]i was increased to
168 ± 5% and 125 ± 4% when compared with the AUC for
control cells (Figure 2B). After addition of 28 µM and 2.8 µM
dipivefrin for 200 seconds, the drug-induced [Ca2+]i increased
to 131 ± 5% and 117 ± 3% (Figure 3A). When cells were
exposed to 68 µM and 6.8 µM brimonidine, the drug-
induced [Ca2+]i was significantly decreased to 44 ± 3% and 76
± 4% (Figure 3B). Two carbonic anhydrase inhibitors,
dorzolamide and brinzolamide, were also evaluated for their
effects on drug-induced [Ca2+]i change. It was found that
dorzolamide at 616 µM and 61.6 µM increased [Ca2+]i to
123 ± 3% and 116 ± 5% (Figure 4A). However, only at 260 µM
Figure 1. Dose-dependent effects of timolol (A) and levobunolol (B) on
[Ca2+]i mobility in cultured bovine corneal endothelial cells. The y-axis
is the area under the curve (AUC) of [Ca2+]i change in cells with baseline
subtracted, where the AUC in the control group is assumed to be a 100%
response. The x-axis presents various concentrations of timolol or
levobunolol for 200 seconds. Data are presented as mean ± SEM (n = 6).
*p < 0.05 compared with the AUC of control cells.
Figure 2. Dose-dependent effects of betaxolol (A) and carteolol (B)
on [Ca2+]i mobility in cultured bovine corneal endothelial cells.
The y-axis is the AUC of [Ca2+]i change in cells with baseline subtracted,
where the AUC in the control group is assumed to be a 100% response.
The x-axis presents various concentrations of betaxolol or carteolol for
200 seconds. Data are presented as mean ± SEM (n = 6). *p < 0.05
compared with the AUC of control cells.
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Figure 4. Dose-dependent effects of dorzolamide (A) and brinzolamide
(B) on [Ca2+]i mobility in cultured bovine corneal endothelial cells. The
y-axis is the AUC of [Ca2+]i change in cells with baseline subtracted,
where the AUC in the control group is assumed to be a 100% response.
The x-axis presents various concentrations of dorzolamide or
brinzolamide for 200 seconds. Data are presented as mean ± SEM (n = 6).
*p < 0.05 compared with the AUC of control cells.
Figure 3. Dose-dependent effects of dipivefrin (A) and brimonidine (B)
on [Ca2+]i mobility in cultured bovine corneal endothelial cells. The
y-axis is the AUC of [Ca2+]i change in cells with baseline subtracted,
where the AUC in the control group is assumed to be a 100% response.
The x-axis presents various concentrations of dipivefrin or brimonidine
for 200 seconds. Data are presented as mean ± SEM (n = 6). *p < 0.05
compared with the AUC of control cells.
did brinzolamide increase the [Ca2+]i concentration to 119
brinzolamide 5% (Figure 4B). In the case of latanoprost,
only the 1.1 µM concentration induced a [Ca2+]i increase to
123 ± 5% (Figure 5A). However, unoprostone concentrations
of 28.2 µM, 2.82 µM, and 0.282 µM all significantly induced
[Ca2+]i increases to 214 ± 5%, 159 ± 3%, and 123 ± 4% (Figure
5B). In the presence of the parasympathomimetic drug
pilocarpine for 200 seconds, the [Ca2+]i was induced by
408 µM and 40.8 µM concentrations to 135 ± 3% and
115 ± 4% (Figure 6A). In the case of the preservative
benzalkonium chloride, the [Ca2+]i area was not affected after
addition of drugs with 0.001, 0.000,1, and 0.000,01 mg/mL
for 200 seconds (Figure 6B).
DISCUSSION
Our data show that most ocular hypotensive agents,
including betaxolol, timolol, levobunolol, carteolol,
dipivefrin, dorzolamide, brinzolamide, latanoprost,
unoprostone, and pilocarpine, have potential to increase
the basal cellular [Ca2+]i,whereas brimonidine inhibits the
[Ca2+]i concentration in cultured BCE cells.
It is known that calcium plays an important role in the
regulation of physiologic functions and pharmacologic
responses such as cellular pump function [6] and cellular
migration [11]. Responses mediated by endothelin-1 [9],
ATP [12], and thrombin [13] all involve the increase of [Ca2+]i
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Figure 6. Dose-dependent effects of pilocarpine (A) and benzalkonium
chloride (B) on [Ca2+]i mobility in cultured bovine corneal endothelial
cells. The y-axis is the AUC of [Ca2+]i change in cells with baseline
subtracted, where the AUC in the control group is assumed to be a 100%
response. The x-axis presents various concentrations of pilocarpine or
benzalkonium chloride for 200 seconds. Data are presented as mean ±
SEM (n = 6). *p < 0.05 compared with the AUC of control cells.
mobility in corneal endothelial cells. Various calcium
channel antagonists have also been found to inhibit
intracellular Ca+2 mobilization of the corneal endothelial
cells and cause corneal swelling [7]. According to our
previously published data, the [Ca2+]i in cultured porcine
corneal endothelial cells was inhibited by isoproterenol and
norepinephrine, yet enhanced by propranolol [8]. In the
present study, we found that many β-adrenergic antagonists,
including betaxolol, timolol, levobunolol, and carteolol,
all increased [Ca2+]i significantly with 1/100 and 1/1,000
concentrations. Thus, the [Ca2+]i mobility in corneal
endothelial cells may be increased by β-adrenergic
antagonists and suppressed by agonists.
In human corneas, endothelial wound healing is
predominantly by stimulation of cell migration. The decrease
of [Ca2+]i in endothelial cells may reduce the contraction of
actin filaments after wound healing migration [14]. Based
upon the response of calcium channel blockers in the
cornea, it has been demonstrated that calcium channels are
presented in corneal endothelial cells. Verapamil, a
phenylalkylamine calcium channel antagonist, blocks the
L-type calcium channel to a far greater extent than the
T-type calcium channel, increasing the swelling rate of
the cornea. In contrast, nifedipine and diltiazem, which
also inhibit L-type channel activity in other tissues [15,16],
exerted no effect on the corneal swelling rate [7]. This
Figure 5. Dose-dependent effects of latanoprost (A) and unoprostone (B)
on [Ca2+]i mobility in cultured bovine corneal endothelial cells. The
y-axis is the AUC of [Ca2+]i change in cells with baseline subtracted,
where the AUC in the control group is assumed to be a 100% response.
The x-axis presents various concentrations of latanoprost or unoprostone
for 200 seconds. Data are presented as mean ± SEM (n = 6). *p < 0.05
compared with the AUC of control cells.
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indicates that corneal endothelial calcium channels exhibit
a different sensitivity to different L-type calcium channel
blockers. The intracellular calcium blocker of TMB-8,
which blocks calcium release from intracellular stores
including ER and interruption of calcium metabolism [17],
also causes an increase in corneal swelling rate [7]. Thus,
any agent that inhibits [Ca2+]i in corneal endothelium may
alter the corneal physiologic function (e.g. decreasing
endothelial pumping activity, then increasing the corneal
swelling rate).
Brimonidine is an α2-adrenergic agent currently used
to lower intraocular pressure in glaucomatous patients
[18]. One report showed that the α2-adrenoceptor agonist
decreased the intracellular Cl– concentration in cultured
rabbit corneal endothelium [19]. It is accepted that the
maintenance of stromal hydration by the corneal
endothelium relies on active transendothelial anion
transporters such as HCO3
– and Cl– with the anions
carrying the current [20]. Although the mechanism for
brimonidine-induced [Ca2+] i. decrease in corneal
endothelial cells is still unknown, this decrease may be
involved in the regulation of pump function in corneal
endothelial cells.
Dipivefrin is a dipivalyl-epinephrine drug. It is
hydrolyzed to the active drug, epinephrine, by esterases in
the cornea [21]. It is difficult to interpret the mechanism of
dipivefrin-induced [Ca2+]i increase in corneal endothelial
cells, because dipivefrin may affect the physiologic response
in corneal endothelial cells by activation of adrenergic β
and/or α receptors.
In the case of dorzolamide, brinzolamide, latanoprost,
unoprostone, and pilocarpine, however, few studies have
been reported on these drugs with respect to the changes
and regulative mechanisms of [Ca2+]i mobility in corneal
endothelial cells.
In summary, [Ca2+]i mobility in corneal endothelial cells
was significantly changed by all commercial antiglaucoma
drugs; this change may affect the physiologic function in
the cornea. Thus, long-term use of antiglaucoma drugs in
patients must be carefully monitored with respect to the
corneal endothelial changes.
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